Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains

被引:15
作者
Cooper, R
Segal, H
Lastovica, AJ
Elisha, BG
机构
[1] Univ Cape Town, Sch Med, Div Med Microbiol, ZA-7925 Cape Town, South Africa
[2] Groote Schuur Hosp, ZA-7925 Cape Town, South Africa
关键词
D O I
10.1046/j.1365-2672.2002.01650.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: The aims of this study were to investigate the epidemiology of quinolone-resistant and -susceptible porcine isolates of Campylobacter coli and to characterize the genetic basis of quinolone resistance. Methods and Results: Penner serotyping and flagellin gene sequence polymorphisms were used to investigate the epidemiology of the C. coli isolates. A total of 55 isolates were included, of which 30 were paired resistant and susceptible isolates from 15 pigs. Amplification of gyrA , gyrB and parC , followed by direct sequencing of amplicons was used to identify mutations in the targets of quinolones. Overall, 31 of the isolates were resistant to ciprofloxacin (minimum inhibitory concentrations (MIC), 2- greater than or equal to 32 mug ml(-1) ). Thirteen Dde I-flaA profiles were observed and resistant and susceptible strains were identified for nine profiles. The majority of resistant strains exhibited either profile 1 or 6. While profile 1 comprised susceptible and resistant strains, all of the strains with profile 6 were resistant to ciprofloxacin. The serogroup (O:24) of the profile 6 strains was identical. The only other serogroup to be uniformly associated with quinolone resistance was O:5. Strains with this phenotype comprised a number of genotypes, including profile 1. Only four of the paired isolates from individual pigs had the same profile. The genetic basis of quinolone resistance was investigated in two strains with ciprofloxacin MICs of 2 and greater than or equal to 32 mug ml(-1) , respectively. The amino acid substitution of isoleucine for threonine at position 86 was identified in the GyrA proteins from both strains. No mutations were identified in the GyrB proteins. Conclusions: There was an association between two of the genotypes, serotypes 5 and 24, and quinolone resistance. The association between genotype, serotype and resistance in C. coli isolates has not been reported previously. Only the mutation in GyrA associated with quinolone resistance was identified. No mutations in GyrB were identified. Amplification products of parC were not obtained and it may be that this gene is not present in some Campylobacter spp. Significance and Impact of the Study: This study provides data on the distribution of ciprofloxacin resistance between subtypes of C. coli .
引用
收藏
页码:241 / 249
页数:9
相关论文
共 37 条
[1]   Campylobacter jejuni -: An emerging foodborne pathogen [J].
Altekruse, SF ;
Stern, NJ ;
Fields, PI ;
Swerdlow, DL .
EMERGING INFECTIOUS DISEASES, 1999, 5 (01) :28-35
[2]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[3]  
[Anonymous], 1999, Clin Microbiol Infect, V5, P239, DOI 10.1111/j.1469-0691.1999.tb00135.x
[4]   Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from The Netherlands [J].
Bootsma, HJ ;
Troelstra, A ;
vanVeenRutgers, A ;
Mooi, FR ;
deNeeling, AJ ;
Overbeek, BP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) :292-293
[5]   Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan Medical Center [J].
Chen, JY ;
Siu, LK ;
Chen, YH ;
Lu, PL ;
Ho, M ;
Peng, CF .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2001, 7 (01) :47-53
[6]   QUINOLONE RESISTANCE IN CAMPYLOBACTER ISOLATED FROM MAN AND POULTRY FOLLOWING THE INTRODUCTION OF FLUOROQUINOLONES IN VETERINARY-MEDICINE [J].
ENDTZ, HP ;
RUIJS, GJ ;
VANKLINGEREN, B ;
JANSEN, WH ;
VANDERREYDEN, T ;
MOUTON, RP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (02) :199-208
[7]   Quinolone and macrolide resistance in Campylobacter jejuni and C-coli:: Resistance mechanisms and trends in human isolates [J].
Engberg, J ;
Aarestrup, FM ;
Taylor, DE ;
Gerner-Smidt, P ;
Nachamkin, I .
EMERGING INFECTIOUS DISEASES, 2001, 7 (01) :24-34
[8]   Ciprofloxacin resistant Campylobacter spp in humans: An epidemiological and laboratory study [J].
Gaunt, PN ;
Piddock, LJV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (04) :747-757
[9]   Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyr4 and parC [J].
Gibreel, A ;
Sjögren, E ;
Kaijser, B ;
Wretlind, B ;
Sköld, O .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3276-3278
[10]   Evidence for recombination in the flagellin locus of Campylobacter jejuni: Implications for the flagellin gene typing scheme [J].
Harrington, CS ;
ThomsonCarter, FM ;
Carter, PE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (09) :2386-2392